Make a donation
Survive Cancer is a small charity, run on a shoestring. Dr Wheatley donates all her time for free, so the administration costs are minimal. This means that the bulk of any money you donate goes straight to setting up the clinical trials.
Dr Wheatley’s orthomolecular research addresses a vital area of cancer treatment, one that the drug companies will not be funding. If the trials are successful, there will be a low-cost solution to two currently intractable medical problems: septic shock and MGUS/Multiple Myeloma.
So we need your help:
How to donate:
Send a cheque made out to Survive Cancer, and send it to:
Survive Cancer, 4 Richmond Road, Oxford OX1 2JJ
Please don’t forget to fill in the Gift Aid form if you are a UK tax payer, print it out and send it with your cheque.
Thank you for your support.
Make a donation today, your support will help us fund our research and trials in the treatment of cancer, sepsis, MGUS and many other diseases.
Septic Shock & Cancer
PROPOSED PATIENT TRIAL
Survive Cancer is hoping to run a patient trial to test very high doses of vitamin B12 in the treatment of septic shock.
What is Septic Shock?
Septic shock kills at least 50% of its victims. It happens when the body is overtaken by infection. The circulation fails, the organs collapse and the person can die.
Who gets it?
Examples include children with meningitis, old people with pneumonia, 67% of cancer patients, AIDS patients, transplant patients, accident victims and patients contracting the hospital super-bug MRSA. Avian flu can also result in septic shock.
Why should we do this trial?
Animal trials going back half a century testing B12 in the treatment of septic shock have shown that it works. • Vitamin B12 has a supremely good safety record – in France they use mega doses to treat cyanide poisoning. • Despite the use of antibiotics, there is currently no successful treatment for septic shock. • Drug companies will never fund this trial – there is no commercial value to them, as vitamins are not patentable. • If successful, we would have a cheap treatment which will have worldwide implications for healthcare costs and, quite simply, human life.
The history of the project
Dr Carmen Wheatley set up Survive Cancer in 1999 to promote an integrated approach to cancer treatment. We believe that it is basic commonsense to boost the overall health of your body’s immune system when you are ill, using vitamins, minerals, herbs and other natural therapies – known as orthomolecular medicine – especially when you are undergoing chemo and radio-therapy. (It is estimated that 67% of cancer patients die from infections brought on by a weakened immune system.) During her research into orthomolecular solutions to disease, Carmen found successful animal studies testing vitamin B12 in the treatment of septic and traumatic shock.
Dr Wheatley has published three hypotheses on B12 for septic shock, in respected medical journals. Her work has attracted international interest from scientists in the field of inflammation. Professors from Harvard, London and Milan have offered to collaborate. We have just completed a number of very successful preliminary lab studies at the William Harvey Institute, London, conducted by Professor Mauro Perretti and his colleagues Professor Fulvio D`Acquisto and Dr Andre Sampaio.
Why this is exciting
Rigorous patient trials are essential if we are to test new approaches to disease. Now we have a chance to do just this, with a vitamin that has been proved to have an excellent safety record in high doses, to treat a life-threatening condition which conventional medicine has so far failed to cure. We have the attention of serious, internationally renowned scientists and doctors, eager to test, yes, a vitamin! If it works, it will be a life-saver for millions.
MGUS & Multiple Myeloma
PROPOSED PATIENT TRIAL
Survive Cancer is hoping to raise money to run a small patient trial to test Dr Carmen Wheatley’s hypothesis, which will test vitamin B12 in the treatment of MGUS, the pre-cancer stage, from which 1 out of 4 patients can be expected to progress to Multiple Myeloma, or other related conditions, such as Waldenstrom’s, Chronic Lymphocytic Leukaemia, Myelodysplastic Syndrome, Macroglobulinaemia, Myelofibrosis, Polycythaemia/Vera/Rubra, Essential Thrombocythaemia, and certain lymphomas, such as Lymphocytic Lymphoma.
If and when the money is in place and we have the go ahead, anyone wishing to take part in the trial will be able to contact the participating hospital nearest to them. If you wish us to contact you directly about this, please leave your details. We have published the current protocol, see link (which may be revised before the trial takes place), and we will keep you informed on this site about our progress in setting up the trial.
Depending on the results of this patient trial to test vitamin B12 in the treatment of MGUS, the charity plans to do a follow-up trial to test vitamin B12 in the treatment of Multiple Myeloma.